Deirdre Egan

1.2k citations

26 papers · 955 indexed · h-index 15

Impact in

Virology top 2%
- HIV Research and Treatment
Infectious Diseases top 2%
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions
- Tuberculosis Research and Epidemiology

Papers in ⓘ

Virology 9
- HIV Research and Treatment 9
Infectious Diseases 21
- HIV/AIDS drug development and treatment 19
- HIV/AIDS Research and Interventions 3
- Tuberculosis Research and Epidemiology 2

Co-authors: Andrew Owen (15 shared papers)David Back (13 shared papers)Saye Khoo (14 shared papers)Marta Boffito (9 shared papers)Laura Else (9 shared papers)Sonia Rodríguez‐Nóvoa (1 shared paper)Judit Morelló (1 shared paper)Lorena Cuenca‐Bermejo (1 shared paper)
Journals: Antimicrobial Agents and Chemotherapy (5 papers)Clinical Pharmacology & Therapeutics (3 papers)JAIDS Journal of Acquired Immune Deficiency Syndromes (2 papers)International Journal of STD & AIDS (2 papers)Bioanalysis (2 papers)
Partner nations: United Kingdom South Africa Nigeria

In The Last Decade

Deirdre Egan

26 papers receiving 944 citations

Peers

Countries citing papers authored by Deirdre Egan

Since Specialization

Citations

This map shows the geographic impact of Deirdre Egan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deirdre Egan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deirdre Egan more than expected).

Fields of papers citing papers by Deirdre Egan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deirdre Egan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deirdre Egan. The network helps show where Deirdre Egan may publish in the future.

Co-authors

The 25 scholars most cited alongside Deirdre Egan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Deirdre Egan Line = papers co-authored together Deirdre Egan links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Predictors of Kidney Tubular Dysfunction in HIV‐Infected Patients Treated with Tenofovir: A Pharmacogenetic Study Clinical Infectious Diseases ·Sonia Rodríguez‐Nóvoa, Pablo Labarga, Vincent Soriano, Deirdre Egan, Marta Albalater, Judit Morelló, Lorena Cuenca‐Bermejo, Gema González‐Pardo, Saye Khoo, David Back, Andrew Owen	2009	194
2	HIV protease inhibitors are substrates for OATP1A2, OATP1B1 and OATP1B3 and lopinavir plasma concentrations are influenced by SLCO1B1 polymorphisms Pharmacogenetics and Genomics ·Ruben C. Hartkoorn, Wai San Kwan, Victoria Shallcross, Ammara Chaikan, Neill J. Liptrott, Deirdre Egan, Enrique Salcedo Sora, Chloë E. James, Sara Gibbons, Pat G. Bray, David Back, Saye Khoo, Andrew Owen	2010	138
3	The SLCO1B1 rs4149032 Polymorphism Is Highly Prevalent in South Africans and Is Associated with Reduced Rifampin Concentrations: Dosing Implications Antimicrobial Agents and Chemotherapy ·Emmanuel Chigutsa, Marianne E Visser, Rina Swart, Paolo Denti, Sudeep Pushpakom, Deirdre Egan, Nicholas H. G. Holford, Peter J. Smith, Gary Maartens, Andrew Owen, Helen McIlleron	2011	114
4	A Compartmental Pharmacokinetic Evaluation of Long-Acting Rilpivirine in HIV-Negative Volunteers for Pre-Exposure Prophylaxis Clinical Pharmacology & Therapeutics ·Akil Jackson, Laura Else, Pedro M. M. Mesquita, Deirdre Egan, David Back, Zeenat Karolia, Lisa Ringner-Nackter, Chris Higgs, Betsy C. Herold, B G Gazzard, Marta Boffito	2014	89
5	Pharmacokinetic and Pharmacodynamic Comparison of Once‐Daily Efavirenz (400 mg vs. 600 mg) in Treatment‐Naïve HIV‐Infected Patients: Results of the ENCORE1 Study Clinical Pharmacology & Therapeutics ·Laura Dickinson, Janaki Amin, Laura Else, Marta Boffito, Deirdre Egan, Andrew Owen, SH Khoo, David Back, Catherine Orrell, Amanda Clarke, Marcelo Losso, Praphan Phanuphak, Dianne Carey, D. A. Cooper, Sean Emery, Rebekah Puls	2015	59
6	Cytochrome P450 2B6 516G→T is associated with plasma concentrations of nevirapine at both 200 mg twice daily and 400 mg once daily in an ethnically diverse population HIV Medicine ·TW Mahungu, Colette Smith, Faye Turner, Deirdre Egan, M Youle, MA Johnson, Saye Khoo, DJ Back, Andrew Owen	2009	54
7	Comprehensive Pharmacokinetic, Pharmacodynamic and Pharmacogenetic Evaluation of Once-Daily Efavirenz 400 and 600 mg in Treatment-Naïve HIV-Infected Patients at 96 Weeks: Results of the ENCORE1 Study Clinical Pharmacokinetics ·Laura Dickinson, Janaki Amin, Laura Else, Marta Boffito, Deirdre Egan, Andrew Owen, Saye Khoo, David Back, Catherine Orrell, Amanda Clarke, Marcelo Losso, Praphan Phanuphak, Dianne Carey, David A. Cooper, Sean Emery, Rebekah Puls	2015	38
8	Antigen Presentation by an Immature Myeloid Dendritic Cell Line Does Not Cause CTL Deletion In Vivo, but Generates CD8+ Central Memory-Like T Cells That Can Be Rescued for Full Effector Function The Journal of Immunology ·Hélène Dumortier, Geertje J. D. van Mierlo, Deirdre Egan, Willem van Ewijk, René E. M. Toes, Rienk Offringa, Cornelis J.M. Melief	2005	35
9	Genetic Determinants of the Pharmacokinetic Variability of Rifampin in Malawian Adults with Pulmonary Tuberculosis Antimicrobial Agents and Chemotherapy ·Derek J. Sloan, Andrew D. McCallum, Alessandro Schipani, Deirdre Egan, Henry C. Mwandumba, Stephen A. Ward, David Waterhouse, Gertrude Mulenga Banda, Theresa J. Allain, Andrew Owen, Saye Khoo, Geraint Davies	2017	34
10	The development and application of a novel LC–MS/MS method for the measurement of Dolutegravir, Elvitegravir and Cobicistat in human plasma Journal of Chromatography B ·Sujan Dilly Penchala, Sandra Fawcett, Laura Else, Deirdre Egan, Alieu Amara, Emilie R Elliot, Elizabeth Challenger, David Back, Marta Boffito, Saye Khoo	2016	29
11	Plasma and Intracellular (Peripheral Blood Mononuclear Cells) Pharmacokinetics of Once-Daily Raltegravir (800 Milligrams) in HIV-Infected Patients Antimicrobial Agents and Chemotherapy ·José Moltó, Marta Valle, David Back, Samandhy Cedeño, Victoria Watson, Neill J. Liptrott, Deirdre Egan, Cristina Miranda, M.J. Barbanoj, Bonaventura Clotet	2010	25
12	Brief Report: Pharmacokinetic/Pharmacodynamic Investigation of Single-Dose Oral Maraviroc in the Context of HIV-1 Pre-exposure Prophylaxis JAIDS Journal of Acquired Immune Deficiency Syndromes ·Julie Fox, Juan Tiraboschi, Carolina Herrera, Laura Else, Deirdre Egan, Laura Dickinson, Akil Jackson, Natalia Olejniczak, David Back, Saye Khoo, Robin J. Shattock, Marta Boffito	2016	23
13	Estimation of the Effect of Slco1B1 Polymorphisms on Lopinavir Plasma Concentration in HIV-Infected Adults Antiviral Therapy ·Alessandro Schipani, Deirdre Egan, Laura Dickinson, Geraint Davies, Marta Boffito, Mike Youle, Saye Khoo, David Back, Andrew Owen	2012	21
14	A Population Pharmacokinetic Analysis Shows that Arylacetamide Deacetylase (AADAC) Gene Polymorphism and HIV Infection Affect the Exposure of Rifapentine Antimicrobial Agents and Chemotherapy ·Jose Francis, Simbarashe Zvada, Paolo Denti, Mark Hatherill, Salome Charalambous, Stanley Mungofa, Rodney Dawson, Susan E. Dorman, Nikhil Gupte, Lubbe Wiesner, Amina Jindani, Thomas S. Harrison, Adeniyi Olagunju, Deirdre Egan, Andrew Owen, Helen McIlleron	2019	20
15	CYP3A422 (c.522-191 C>T; rs35599367) is associated with lopinavir pharmacokinetics in HIV-positive adults Pharmacogenetics and Genomics* ·Adeniyi Olagunju, Alessandro Schipani, Marco Siccardi, Deirdre Egan, Saye Khoo, David Back, Andrew Owen	2014	20
16	Quantification of Rilpivirine in Human Plasma, Cervicovaginal Fluid, Rectal Fluid and Genital/Rectal Mucosal Tissues Using Liquid Chromatography–Tandem Mass Spectrometry Bioanalysis ·Laura Else, John Tjia, Akil Jackson, Sujan Dilly Penchala, Deirdre Egan, Marta Boffito, Saye Khoo, David Back	2014	12
17	Polymorphisms of tenofovir disoproxil fumarate transporters and risk of kidney tubular dysfunction in HIV-positive patients: genetics of tenofovir transporters International Journal of STD & AIDS ·Mohammed Danjuma, Deirdre Egan, Ibrahim Y. Abubeker, Frank A. Post, Saye Khoo	2018	11
18	Effect of SLCO1B1 Polymorphisms on Rifabutin Pharmacokinetics in African HIV-Infected Patients with Tuberculosis Antimicrobial Agents and Chemotherapy ·Stefanie Hennig, (unknown), Tarylee Reddy, Deirdre Egan, Tracy Kellerman, Lubbe Wiesner, Andrew Owen, Helen McIlleron, Alexander S. Pym	2015	10
19	Pharmacokinetic/pharmacodynamic investigation of raltegravir with or without lamivudine in the context of HIV-1 pre-exposure prophylaxis (PrEP) Journal of Antimicrobial Chemotherapy ·Carolina Herrera, Julianne Lwanga, Ming Lee, Suna Mantori, Alieu Amara, Laura Else, Sujan Dilly Penchala, Deirdre Egan, Elizabeth Challenger, Laura Dickinson, Marta Boffito, Robin J. Shattock, Saye Khoo, Julie Fox	2021	9
20	The Relationships of ABCB1 3435C>T and CYP2B6 516G>T With High-Density Lipoprotein Cholesterol in HIV-Infected Patients Receiving Efavirenz Clinical Pharmacology & Therapeutics ·TW Mahungu, D.R. Nair, Colette Smith, Deirdre Egan, M Youle, M. A. Johnson, SH Khoo, DJ Back, Andrew Owen	2009	8

About Deirdre Egan

Deirdre Egan is a scholar working on Virology, Infectious Diseases, Pediatrics, Perinatology and Child Health, Oncology and Pharmacology, having authored 26 papers that have together received 955 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (19 papers), Pharmacological Effects and Toxicity Studies (10 papers), HIV Research and Treatment (9 papers), Drug Transport and Resistance Mechanisms (9 papers), Pneumocystis jirovecii pneumonia detection and treatment (3 papers), HIV/AIDS Research and Interventions (3 papers), HIV-related health complications and treatments (2 papers) and Tuberculosis Research and Epidemiology (2 papers). The work is most often cited by research in Virology (356 citations), Infectious Diseases (730 citations), Emergency Medicine (137 citations), Pharmacology (100 citations) and Pediatrics, Perinatology and Child Health (223 citations). Deirdre Egan has collaborated with scholars based in United Kingdom, South Africa and Nigeria. Frequent co-authors include Andrew Owen, David Back, Saye Khoo, Marta Boffito, Laura Else, Sonia Rodríguez‐Nóvoa, Judit Morelló, Lorena Cuenca‐Bermejo, Gema González‐Pardo and Pablo Labarga. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Clinical Pharmacology & Therapeutics, JAIDS Journal of Acquired Immune Deficiency Syndromes, International Journal of STD & AIDS and Bioanalysis.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact